Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC

Clinical trial NCT00786331 · UNKNOWN

Trial details

NCT number: NCT00786331
Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Non-Small Cell Lung Cancer

Start date: 2007-07-01
Primary completion: 2009-07-01
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.